首页 / 院系成果 / 成果详情页

Stroke in China: advances and challenges in epidemiology, prevention, and management  期刊论文   WOS高被引论文

  • 编号：
    b6711ca4-9eea-4772-9fee-de5152b76d30
  • 作者：
    Wu, Simiao[1];Wu, Bo[1];Liu, Ming[1,2,3];Chen, Zhengming[4,5];Wang, Wenzhi[6];Anderson, Craig S.[12,13,14];Sandercock, Peter[15];Wang, Yongjun[7];Huang, Yining[16];Cui, Liying[17];Pu, Chuanqiang[18];Jia, Jianping[8];Zhang, Tong[9,11];Liu, Xinfeng[19];Zhang, Suming[20];Xie, Peng[21];Fan, Dongsheng[22,23];Ji, Xunming[10];Wong, KaSing Lawrence[24];Wang, Longde[25];Wei, Chenchen[1];Wang, Yanan[1];Cheng, Yajun[1];Zhou, Dong[1];He, Li[1];Liu, Junfeng[1];Zhang, Shuting[1];Tao, Wendan[1];Hao, Zilong[1];Wang, Deren[1];Zhang, Shihong[1];Liu, Yunhai[26];Li, Xin[27];Dong, Qiang(董强)[28]Zeng, Jinsheng[29,30];Peng, Bin[17];Xu, Yun[31];Yang, Yi[32];Wang, Yilong[7];Li, Zixiao[7];Zhao, Gang[33];Wang, Wei[20];Xu, Yuming[34];Yang, Qingwu[35];He, Zhiyi[36];Wang, Shaoshi[37];You, Chao[38];Gao, Ying[39];Yang, Jie[40,41,42,43];Lei, Chunyan[44];Zhao, Yuhua[45];
  • 语种：
    英文
  • 期刊：
    LANCET NEUROLOGY ISSN：1474-4422 2019 年 18 卷 4 期 (394 - 405) ; APR
  • 收录：
     
  • 摘要：

    With over 2 million new cases annually, stroke is associated with the highest disability-adjusted life-years lost of any disease in China. The burden is expected to increase further as a result of population ageing, an ongoing high prevalence of risk factors (eg, hypertension), and inadequate management. Despite improved access to overall health services, the availability of specialist stroke care is variable across the country, and especially uneven in rural areas. In-hospital outcomes have improved because of a greater availability of reperfusion therapies and supportive care, but adherence to secondary prevention strategies and long-term care are inadequate. Thrombolysis and stroke units are accepted as standards of care across the world, including in China, but bleeding-risk concerns and organisational challenges hamper widespread adoption of this care in China. Despite little supporting evidence, Chinese herbal products and neuroprotective drugs are widely used, and the increased availability of neuroimaging techniques also results in overdiagnosis and overtreatment of so-called silent stroke. Future efforts should focus on providing more balanced availability of specialised stroke services across the country, enhancing evidence-based practice, and encouraging greater translational research to improve outcome of patients with stroke.

  • 推荐引用方式
    GB/T 7714：
    Wu Simiao,Wu Bo,Liu Ming, et al. Stroke in China: advances and challenges in epidemiology, prevention, and management [J].LANCET NEUROLOGY,2019,18(4):394-405.
  • APA：
    Wu Simiao,Wu Bo,Liu Ming,Chen Zhengming,&Zhao Yuhua.(2019).Stroke in China: advances and challenges in epidemiology, prevention, and management .LANCET NEUROLOGY,18(4):394-405.
  • MLA：
    Wu Simiao, et al. "Stroke in China: advances and challenges in epidemiology, prevention, and management" .LANCET NEUROLOGY 18,4(2019):394-405.
  • 条目包含文件：
    文件类型：PDF,文件大小：
    正在加载全文
浏览次数：56 下载次数：0
分享到：
浏览次数：56
下载次数：0
打印次数：0

网站总浏览量： 次   

Copyright © 复旦大学上海医学院机构知识仓储平台

技术支持：北京同舟云网络信息技术有限公司

浏览器支持: Google Chrome   火狐   360浏览器极速模式(8.0+极速模式) 
返回顶部